Klinikum Mutterhaus der Borromäerinnen

Hospital


Location: Trier, Germany (DE) DE

ISNI: -

ROR: https://ror.org/03cn8n632

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C (2022) De Gregorio A, Janni W, Friedl TWP, Nitz U, Rack B, Schneeweiss A, Kates R, et al. Journal article Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial (2020) Fietkau R, Hecht M, Hofner B, Lubgan D, Iro H, Gefeller O, Rödel C, et al. Journal article Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer (2019) Fietkau R, Hecht M, Hofner B, Iro H, Gefeller O, Roedel C, Hautmann M, et al. Conference contribution Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) (2017) Heinz WJ, Buchheidt D, Christopeit M, Von Lilienfeld-Toal M, Cornely OA, Einsele H, Karthaus M, et al. Journal article, Review article The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial (2017) Jaeger BAS, Neugebauer J, Andergassen U, Melcher C, Schochter F, Mouarrawy D, Ziemendorff G, et al. Journal article Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV (2016) Miranda MB, Lauseker M, Kraus MP, Proetel U, Hanfstein B, Fabarius A, Baerlocher GM, et al. Journal article Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial (2015) Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, et al. Journal article